Navigating U.S. Market Entry for MedTech Developers with JJ Amell

When you develop a groundbreaking medical device, you assume the engineering and clinical data will carry you across the finish line. The legal landscape of U.S. market entry involves layers of corporate traps that most innovators completely overlook. In this episode of the Med Device Cyber Podcast, Christian and Trevor sit down with JJ Amell, the founder of Amell Law, to unpack the complex realities of international corporate structuring, business immigration, and intellectual property protection.JJ shares his unique transition from building computers and working within his father's cardiology practice to guiding international medical technology firms through federal bureaucracy. The trio explores why setting up a basic LLC through automated online legal platforms leaves multi-million dollar startups exposed to catastrophic liability. They break down the tactical timing of securing O-1 founder visas and investor visas before state borders close behind you, and analyze the shifting corporate battleground between Delaware and Texas for control over majority shareholder decisions. The specifics may differ, but the challenge is the same: protecting what you've built. This conversation covers everything from Customs and Border Protection issues to defending service marks against public database scrapers.Episode Breakdown:00:00 - Intro00:54 - Welcoming MedTech attorney JJ Amell03:38 - Solving legal pain points for global innovators06:11 - The three pillars of U.S. market entry08:33 - The inverse market challenge: Moving from Europe to the U.S.10:43 - Factoring in fiscal repercussions and international tax consultations12:57 - State jurisdictions: Delaware standards vs Texas corporate law16:21 - California red tape and the rise of alternative technology hubs22:41 - Reverse engineering corporate strategy to avoid late-stage corrections25:44 - The danger of automated penetration tests and interactive FDA reviews29:39 - Deportation risks and B-1/B-2 tourist visa limitations31:24 - Government bureaucracy timelines and USPTO trademark processing realities33:04 - Public database scraping and the explosion of corporate filing scams37:37 - AI voice cloning and deepfake vulnerabilities targeting tech executives40:52 - Code Blue Chart: Documented cybersecurity fatalities in healthcare44:25 - Closing thoughts and reconnecting with natureFind JJ Amell here on LinkedIn: https://www.linkedin.com/in/jjamellesq/The Med Device Cyber Podcast is brought to you by Blue Goat Cyber, cybersecurity experts providing essential security solutions for the medical device industry. Learn more by visiting https://bluegoatcyber.com.If you're interested in our services or partnering with us, schedule a Discovery Session: https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-sessionChristian Espinosa is the CEO and founder of Blue Goat Cyber. Trevor Slattery is the Chief Operating Officer at Blue Goat Cyber.Christian Espinosa on LinkedIn: https://www.linkedin.com/in/christianespinosa/Trevor Slattery on LinkedIn: https://www.linkedin.com/in/trevor-slattery-34852b1a9Blue Goat Cyber on LinkedIn: https://www.linkedin.com/company/blue-goat-cyber/Blue Goat Cyber on Instagram: https://www.instagram.com/bluegoatcyber/Blue Goat Cyber on Facebook: https://www.facebook.com/bluegoatcyber/Blue Goat Cyber on YouTube: https://www.youtube.com/@BlueGoatCyber/?sub_confirmation=1